Patents Assigned to Allelix-Pharm-Eco L.P.
  • Slow-onset, long-lasting dopamine reuptake blockers
    Patent number: 6011070
    Abstract: Disclosed is a method of treating an individual who abuses cocaine by administering to the individual a therapeutically effective amount of an N,N-dialkyl 3-phenyl-1-indanamine or a mixture of N,N-dialkyl 3-phenyl-1-indanamines. Also disclosed is a method of treating an individual with Parkinson's disease or attention deficit hyperactivity disorder by administering to the individual a therapeutically effective amount of an N,N-dialkyl 3-phenyl-1-indanamine or a mixture of N,N-dialkyl 3-phenyl-1-indanamines.
    Type: Grant
    Filed: August 15, 1997
    Date of Patent: January 4, 2000
    Assignee: Allelix-Pharm-Eco L.P.
    Inventors: Mark Froimowitz, Kuo-Ming Wu
  • Compounds for treating cocaine abuse
    Patent number: 5821386
    Abstract: Disclosed are novel compounds which are dopamine reuptake blockers for treating cocaine abuse. The compounds are represented by the following structural formula: ##STR1## R2 is n-propyl, iso-propyl, n-butyl, sec-butyl, or tert-butyl. Phenyl Ring B is unsubstituted or substituted with one, two or three substituents.
    Type: Grant
    Filed: August 15, 1997
    Date of Patent: October 13, 1998
    Assignee: Allelix-Pharm-Eco L.P.
    Inventors: Mark Froimowitz, Kuo-Ming Wu